BridgeBio Oncology Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell BBOT and other ETFs, options, and stocks.About BBOT
Bridgebio Oncology Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It focuses on advancing a next-generation pipeline of novel small molecule therapeutics targeting RAS and PI3Ka malignancies.
CEOEli M. Wallace
CEOEli M. Wallace
Employees—
Employees—
HeadquartersSouth San Francisco, California
HeadquartersSouth San Francisco, California
Founded2016
Founded2016
Employees—
Employees—
BBOT Key Statistics
Market cap1.04B
Market cap1.04B
Price-Earnings ratio-13.88
Price-Earnings ratio-13.88
Dividend yield—
Dividend yield—
Average volume215.91K
Average volume215.91K
High today$13.58
High today$13.58
Low today$12.84
Low today$12.84
Open price$12.98
Open price$12.98
Volume17.77K
Volume17.77K
52 Week high$14.87
52 Week high$14.87
52 Week low$8.50
52 Week low$8.50
Stock Snapshot
BridgeBio Oncology Therapeutics(BBOT) stock is priced at $13.06, giving the company a market capitalization of 1.04B. It carries a P/E multiple of -13.88.
On 2025-12-11, BridgeBio Oncology Therapeutics(BBOT) stock traded between a low of $12.84 and a high of $13.58. Shares are currently priced at $13.06, which is +1.7% above the low and -3.8% below the high.
The BridgeBio Oncology Therapeutics(BBOT)'s current trading volume is 17.77K, compared to an average daily volume of 215.91K.
In the last year, BridgeBio Oncology Therapeutics(BBOT) shares hit a 52-week high of $14.87 and a 52-week low of $8.50.
In the last year, BridgeBio Oncology Therapeutics(BBOT) shares hit a 52-week high of $14.87 and a 52-week low of $8.50.
Analyst ratings
100%
of 7 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own BBOT. This list is generated using Robinhood data, and it’s not a recommendation.